Illumina, Inc. (ETR:ILU)
Germany
· Delayed Price · Currency is EUR | Market Cap | 12.07B |
| Revenue (ttm) | 4.19B |
| Net Income (ttm) | -1.17B |
| Shares Out | n/a |
| EPS (ttm) | -7.38 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 2.89 (3.55%) |
| Ex-Dividend Date | n/a |
| Volume | 67 |
| Average Volume | 429 |
| Open | 77.82 |
| Previous Close | 78.66 |
| Day's Range | 75.71 - 77.82 |
| 52-Week Range | 75.71 - 150.56 |
| Beta | 1.13 |
| RSI | 30.97 |
| Earnings Date | Apr 25, 2025 |
About Illumina
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole... [Read more]
Financial Performance
In 2024, Illumina's revenue was $4.37 billion, a decrease of -2.93% compared to the previous year's $4.50 billion. Losses were -$1.22 billion, 5.34% more than in 2023.
Financial numbers in USD Financial StatementsNews
Is Illumina Undervalued After An 83% Drop In Its Stock Price?
Illumina rises after board revamp
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Stephen MacMillan to retire from the Board SAN DIEGO , March 25, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced cha...
Activist investor Keith Meister to join Illumina's board, WSJ reports
Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott Gottlieb will become chairman, the Wall Street Journal reported on Tuesday, citin...
Activist Investor Meister to Join Illumina's Board
Keith Meister's hedge fund Corvex Management has a 2.5% stake in the gene-sequencing machine maker.
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen
On Friday, March 21, 2025, the Cathie Wood -led Ark Invest made some notable trades, including significant buys and sells. Ark Invest's fund bought Iridium Communications Inc. (NASDAQ: IRDM), Beam Th...
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
Creates one of the largest, most comprehensive clinical genomic datasets of its kind; multiomic data to be added in next phase of program AGD members are using the population-level insights to u...
Jim Cramer Says Illumina Is 'Challenged,' Recommends Selling This Industrial Stock
On CNBC's “ Mad Money Lightning Round, “ Jim Cramer recommended selling NANO Nuclear Energy Inc. (NASDAQ: NNE). On March 7, NANO Nuclear Energy announced that Florent Heidet, Ph.D. has joined NANO Nu...
Lightning Round: Nano Nuclear Energy is a sell, says Jim Cramer
'Mad Money' host Jim Cramer weighs in on stocks including: Illumina, Nano Nuclear Energy, Steris, Lam Research, Arista Networks and more.
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20% . China responded to Trump’s recent tariff...
Diagnostic Kit Maker Illumina To Cut $100 Million In Costs, Lowers 2025 Profit Outlook Amid China Trade Restrictions
On Monday, Illumina Inc. (NASDAQ: ILMN) said that it is implementing cost cuts of approximately $100 million in fiscal year 2025 in response to China's recent ban on importing its sequencers . Last w...
Stocks to Watch Tuesday: Tesla, Oracle, Delta, Illumina
Illumina lowers guidance, cuts spending to mitigate China ban on its gene sequencers
Illumina lowers outlook due to China sales ban, to cut $100 million in costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.
Illumina addresses recent developments in China
Announces Fiscal Year 2025 Non-GAAP Diluted EPS of Approximately $4.50 SAN DIEGO , March 10, 2025 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the Mar...
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Beijing banned imports of Illumina's gene-sequencing machines in response to U.S. tariffs.
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
Illumina leads as highest-scoring U.S. company in its industry SAN DIEGO , March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, ...
Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN stock.
What's Left of Illumina's China Business After Tariff Retaliation: Heard on the Street
Last month Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese government added the maker of gene-sequencing equipment to its list of “...
Illumina Stock Slammed As China Retaliates Against Trump's Tariffs
Illumina stock skidded Tuesday after China signaled it would ban the company from importing its gene-mapping products.
US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War
China has banned imports of genetic sequencers from Illumina Inc . (NASDAQ: ILMN), just minutes after U.S. President Donald Trump’s additional 10% tariff on Chinese goods took effect. China hit back ...
US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War
China has banned imports of genetic sequencers from Illumina Inc. ILMN, just minutes after U.S. President Donald Trump's additional 10% tariff on Chinese goods took effect.
Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology
Illumina was placed on China’s list of ‘unreliable entities’ in February.
Stocks making the biggest moves premarket: Nvidia, Tesla, Target, Illumina and more
These are the stocks posting some of the largest moves in premarket trading.
Stocks to Watch Tuesday: Target, Illumina, Nvidia, Stellantis
↘️ Illumina (ILMN): Beijing said it would ban the U.S. biotech from [exporting gene sequencers to China](https://www.wsj.com/livecoverage/trump-tariffs-canada-mexico-china-stock-market-today-03-04-202...